发明名称 |
Tumor cell-killing peptides |
摘要 |
The present invention provides a tumor cell-killing peptide and a pharmaceutical composition for treating a cancer. The tumor cell-killing peptide of the present invention selectively homes into tumor cells so that it can induce the death of tumor cells effectively while minimizing the harming of normal cell. |
申请公布号 |
US8877889(B2) |
申请公布日期 |
2014.11.04 |
申请号 |
US201013393394 |
申请日期 |
2010.08.16 |
申请人 |
Industry-Academic Cooperation Foundation, Chosun University |
发明人 |
Kim Tae-Hyoung |
分类号 |
C07K7/00;C07K14/47;A61K38/00 |
主分类号 |
C07K7/00 |
代理机构 |
Clark & Elbing LLP |
代理人 |
Clark & Elbing LLP |
主权项 |
1. A tumor cell-killing peptide, comprising:
(a) a mitochondria targeting domain (MTD) at its C-terminal region consisting of an amino acid sequence selected from the group consisting of the amino acid sequences of SEQ ID NOs:1 and 4-7; and (b) a tumor homing motif at its N-terminal region, consisting of the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:3; and (c) a peptide linker that links the MTD to the tumor homing motif. |
地址 |
Gwangju KR |